Are you Dr. Blazar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 87 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
516 Delaware Street SE
University of MN Physicians PWB Fifth floor Clinic 5B
Minneapolis, MN 55455Phone+1 612-273-2800Fax+1 612-626-4074- Is this information wrong?
Summary
- Dr. Bruce Blazar, MD is a pediatric hematologist/oncologist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with M Health Fairview University of Minnesota Medical Center and is a Regents Professor at University of Minnesota Medical School.
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1982 - 1985
- University of MinnesotaResidency, Pediatrics, 1978 - 1981
- Albany Medical CollegeClass of 1978
Certifications & Licensure
- MN State Medical License 1980 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1996
Publications & Presentations
PubMed
- Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation.Leslie S Kean, Bruce R Blazar> ;The Journal of Clinical Investigation. 2024 Apr 15
- The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert, Kayla Betz, Alison Yu, Sung W Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Mic...> ;Transplantation and Cellular Therapy. 2024 Apr 5
- Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor...> ;Blood. 2024 Mar 6
- Join now to see all
Press Mentions
- CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-MacrophagesApril 26th, 2021
- Magenta Therapeutics Announces Multiple Presentations Across Stem Cell Transplant Portfolio at the American Society of Hematology (ASH) Annual MeetingNovember 4th, 2020
- BlueRock Therapeutics Establishes Key Partnerships with Leading Experts in Autoimmune DiseaseJanuary 16th, 2019
- Join now to see all
Grant Support
- Nontoxic Strategies To Establish Allochimerism In MiceNational Heart, Lung, And Blood Institute2004–2012
- University Of Minnesota Clinical And Translational Science Institute (Umn Ctsi)National Center For Research Resources2011
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2011
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2011
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2011
- T Progenitor And Thymic Epithelial Cell Replacement Post TransplantNational Cancer Institute2010–2011
- Molecular Mechanisms Of Thymic Epithelial Cell Involution In AgingNational Institute On Aging2009–2011
- Role Of Novel Inhibitory Pathways In Alloimmunity And ToleranceNational Institute Of Allergy And Infectious Diseases2009–2011
- Mouse Models Of Chronic Graft-Vs-Host DiseaseNational Cancer Institute2009–2011
- Cytotoxic-T-Lymphocyte (CTL) Therapy Of AMLNational Cancer Institute2007–2011
- T Cell Targeting For GVHDNational Heart, Lung, And Blood Institute1998–2011
- In Vivo Prevention Of Murine GVHDNational Institute Of Allergy And Infectious Diseases1997–2011
- Cellular Approaches To Reduce BMT ComplicationsNational Heart, Lung, And Blood Institute2005–2008
- Post BMT Lung Injury PathophysiologyNational Heart, Lung, And Blood Institute2000–2008
- T Cell Targeting For GVHDNational Heart, Lung, And Blood Institute1998–2007
- Strategies To Prevent And Repair Thymic MicroenvironmentNational Heart, Lung, And Blood Institute2003–2006
- GVL To Reduce AML Relapse After Murine Allogeneic BMTNational Cancer Institute1997–2006
- Correction Of Murine Immunodeficiencies In UteroNational Heart, Lung, And Blood Institute1994–2005
- In Utero Transfer Of Hematopoietic CellsNational Heart, Lung, And Blood Institute2000–2004
- Nontoxic Strategies To Establish AllochimerismNational Heart, Lung, And Blood Institute1999–2002
- Research Training In BMT Biology As Related To CancerNational Cancer Institute1996–2000
- In Utero Transfer Of Murine Hematopoietic CellsNational Heart, Lung, And Blood Institute1997–1998
- Post Bone Marrow Transplant Lung Injury PathophysiologyNational Heart, Lung, And Blood Institute1995–1998
- Liver RejectionNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
- Retroviral Transduction Of Lymphocytes For Anti-Lymphoma TherapyNational Cancer Institute1996–1997
- T-Cell Targeting For GVHDNational Heart, Lung, And Blood Institute1995–1997
- In Utero Transfer Of Murine Hematopoietic Cells In MiceNational Heart, Lung, And Blood Institute1994–1996
- In Vivo Prevention Of Murine Graft-Versus-Host DiseaseNational Institute Of Allergy And Infectious Diseases1993–1996
- Factors Affecting Marrow EngraftmentNational Institute Of Diabetes And Digestive And Kidney Diseases1989
- Factors Affecting Marrow Engraftment In Man And MouseNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
- Factors Affecting Marrow Engraftment In Man And MouseNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota